NCORP Community Site expands access to cancer trials
Official title: Medical University of South Carolina NCORP Community Site
Funded at Medical University of South Carolina · NIH-11543489 · Data updated 2026-11-12
A NCORP community site at MUSC/Hollings Cancer Center is working to include more medically underserved patients in cancer trials and improve how trials are recruited, retained, and delivered in the community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project start | August 1, 2014 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,125,622 |
| NIH project number | 4UG1CA189848-12 |
| Project ID | NIH-11543489 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with cancer who are treated within the MUSC NCORP network and belong to historically underrepresented or medically underserved groups.
✕Less likely to help
Patients outside the NCORP network or those not eligible for ongoing trials may not directly benefit.
What this research studies
This grant supports broadening access to cancer trials by partnering with local clinicians and community affiliates to enroll historically overlooked patient groups. The team shares best practices for recruitment and retention and integrates local knowledge to enhance cancer care delivery research. It funds collaboration among radiology, medical oncology, public health, otolaryngology, and clinical operations to sustain a robust, patient-centered research program. The goal is to make high-quality cancer trials more representative and accessible in the MUSC NCORP network.
Why it matters
Potential benefit: Patients could gain access to innovative cancer treatments through more inclusive trial participation.
How similar studies have gone: NCORP programs have previously increased enrollment of diverse populations into cancer trials with improved access to care.
Where this research is happening
-
Medical University of South Carolina
Charleston, United States Active
Researchers
- Principal investigator: Marshall, David T. — Medical University of South Carolina
- Study coordinator: Marshall, David T.
Related research
Other NIH-funded projects on the same topics.
-
Il1rapl2’s role in shaping cortical wiring in autism
This project studies how a brain gene linked to autism helps form the connections in deep-layer neurons to understand why circuits develop differently in ASD.
-
Neuron-OPC Synaptic Mechanisms Shaping Myelin in Health and Disease
This project looks at how brain cells called oligodendrocyte precursor cells (OPCs) listen to neurons to shape myelin, with potential relevance for autism and related conditions.
-
Synaptic development and sleep-related brain circuits in autism
A study in mice explores how early brain circuits that help sleep become wired, hoping to understand sleep problems in autism.
-
Enteric neuron and intestinal stem cell signals shaping gut barrier
A research project from the Medical University of South Carolina explores how nerve cells in the gut talk to the lining and stem cells to defend the digestive tract, using human organoids and mouse models.
-
Glutamine and macrophage behavior in liver cancer
A funded project at a medical university aims to understand how the liver’s immune cells interact with a specific type of liver cancer by looking at metabolism, especially glutamine and ammonia.
-
Glycoprotein urine markers that signal lupus nephritis treatment response
A novel test uses urine glycoprotein patterns to show how well lupus nephritis is responding to standard treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.